NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
29/04/2025
Voltar para busca
Dado oficial do USPTO
ALPHA-9 THERANOSTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Snapshot rápido
ALPHA-9 THERANOSTICS
ST13
US500000090256438Classe
5, 42
Pedido
90256438
Registro
7773057
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
66
Atualização mais recente
03/04/2026
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
15/10/2020
Data de registro
29/04/2025
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/04/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
VANCOUVER, CA
Examinador
RHIM, ANDREW
Unidade examinadora
L10
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
ALPHA-9 ONCOLOGY INC.
Alpha-9 Theranostics Inc.
Representantes
David C. Lee AKIN GUMP STRAUSS HAUER & FELD LLP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparationsradiotherapeutic preparations and radiodiagnostic preparationsfor the diagnosis and treatment of cancer
Classe 42
Development of medical products in the field of nuclear medicine
Publicações
Histórico de despachos e eventos da marca no USPTO.
66 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
29/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/03/2025
PUBO
PUBLISHED FOR OPPOSITION
11/03/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/03/2025
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
13/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/02/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/02/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/02/2025
GNRT
NON-FINAL ACTION E-MAILED
06/02/2025
CNRT
NON-FINAL ACTION WRITTEN
06/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/01/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/01/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
23/01/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
27/11/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
28/06/2024
GNSL
LETTER OF SUSPENSION E-MAILED
28/06/2024
CNSL
SUSPENSION LETTER WRITTEN
28/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/06/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/06/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
14/04/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
14/04/2024
CNSI
SUSPENSION INQUIRY WRITTEN
14/04/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
12/04/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/10/2023
GNSL
LETTER OF SUSPENSION E-MAILED
11/10/2023
CNSL
SUSPENSION LETTER WRITTEN
11/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/09/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
20/09/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
28/06/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
28/06/2023
CNSI
SUSPENSION INQUIRY WRITTEN
28/06/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
28/06/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/12/2022
GNSL
LETTER OF SUSPENSION E-MAILED
09/12/2022
CNSL
SUSPENSION LETTER WRITTEN
09/12/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/11/2022
ALIE
ASSIGNED TO LIE
22/11/2022
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
05/10/2022
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
04/05/2022
GNSI
INQUIRY TO SUSPENSION E-MAILED
04/05/2022
CNSI
SUSPENSION INQUIRY WRITTEN
04/05/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/05/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
20/09/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/09/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
20/09/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/09/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
08/09/2021
GNSL
LETTER OF SUSPENSION E-MAILED
08/09/2021
CNSL
SUSPENSION LETTER WRITTEN
08/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/08/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/08/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/08/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/03/2021
GNRT
NON-FINAL ACTION E-MAILED
18/03/2021
CNRT
NON-FINAL ACTION WRITTEN
18/03/2021
DOCK
ASSIGNED TO EXAMINER
16/03/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
11/03/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/12/2020
NWAP
NEW APPLICATION ENTERED
19/10/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ALPHA-9 THERANOSTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.